NEOMAB BIO

Serial Number 98394125
Registration 7896288
700

Registration Progress

Application Filed
Feb 6, 2024
Under Examination
Approved for Publication
Jun 3, 2025
Published for Opposition
Jun 3, 2025
Registered
Aug 19, 2025

Trademark Image

NEOMAB BIO

Basic Information

Serial Number
98394125
Registration Number
7896288
Filing Date
February 6, 2024
Registration Date
August 19, 2025
Published for Opposition
June 3, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 19, 2025
Registration
Registered
Classes
042

Rights Holder

GemPharmatech Co., Ltd.

99
Address
12 Xuefu Rd, Jiangbei New Area
Nanjing, Jiangsu 210000
CN

Ownership History

GemPharmatech Co., Ltd.

Original Applicant
99
Nanjing, Jiangsu CN

GemPharmatech Co., Ltd.

Owner at Publication
99
Nanjing, Jiangsu CN

GemPharmatech Co., Ltd.

Original Registrant
99
Nanjing, Jiangsu CN

Legal Representation

Attorney
Nazly Aileen Bayramoglu

USPTO Deadlines

Next Deadline
2019 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250819)
Due Date
August 19, 2031
Grace Period Ends
February 19, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Aug 19, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Aug 19, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 3, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 3, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 28, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 1, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 1, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 1, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 1, 2025 ALIE A ASSIGNED TO LIE Loading...
Apr 17, 2025 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Nov 4, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Nov 4, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Nov 4, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Nov 1, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 1, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 1, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 29, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 4, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 6, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics

Additional Information

Translation
The wording "NEOMAB BIO" has no meaning in a foreign language.
Pseudo Mark
NEO MONOCLONAL ANTIBODY

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"